P474: FUNCTIONAL (PHOSPHO-)PROTEOMICS OF DRUG RESPONSE IN ACUTE MYELOID LEUKEMIA
Main Authors: | Denys Oliinyk, Maximilian Fleischmann, Dilfuza Ernafasova, Caroline Tschernjawski, Sebastian Scholl, Andreas Hochhaus, Florian Meier-Rosar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968804.83594.27 |
Similar Items
-
Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives
by: Maximilian Fleischmann, et al.
Published: (2021-11-01) -
Synergistic Effects of the RAR<i>alpha</i> Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation
by: Maximilian Fleischmann, et al.
Published: (2024-03-01) -
Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments
by: Sebastian Scholl, et al.
Published: (2020-11-01) -
Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia
by: Angela Schumich, et al.
Published: (2020-02-01) -
Polymorphisms of Dectin-1 and TLR2 Predispose to Invasive Fungal Disease in Patients with Acute Myeloid Leukemia.
by: Mike Fischer, et al.
Published: (2016-01-01)